Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

被引:0
|
作者
F Pauly
K Fjordén
S Leppä
H Holte
M Björkholm
Ø Fluge
L Møller Pedersen
M Eriksson
A Isinger-Ekstrand
C A K Borrebaeck
M Jerkeman
C Wingren
机构
[1] Lund University,Department of Immunotechnology
[2] CREATE Health,Department of Oncology
[3] Lund University,Department of Oncology
[4] Lund University,Department of Oncology
[5] Skåne University Hospital,Department of Medicine
[6] Helsinki University Hospital,Department of Oncology
[7] Oslo University Hospital,Department of Hematology
[8] Karolinska University Hospital,undefined
[9] Haukeland University Hospital,undefined
[10] Roskilde Hospital,undefined
来源
Blood Cancer Journal | 2016年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:e501 / e501
相关论文
共 50 条
  • [1] Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study
    Pauly, F.
    Fjorden, K.
    Leppa, S.
    Holte, H.
    Bjorkholm, M.
    Fluge, O.
    Pedersen, L. Moller
    Eriksson, M.
    Isinger-Ekstrand, A.
    Borrebaeck, C. A. K.
    Jerkeman, M.
    Wingren, C.
    BLOOD CANCER JOURNAL, 2016, 6 : e501 - e501
  • [2] Plasma Affinity Proteomic Immunoprofiling As a Novel Prognostic Tool in High Risk Diffuse Large B-Cell Lymphoma Patients: A Nordic Lymphoma Group Study
    Fjorden, Karin
    Pauly, Frida
    Leppa, Sirpa
    Holte, Harald
    Bjorkholm, Magnus
    Fluge, Oystein
    Pedersen, Lars Moller
    Eriksson, Mikael
    Isinger-Ekstrand, Anna
    Borrebaeck, Carl
    Jerkeman, Mats
    Wingren, Christer
    BLOOD, 2014, 124 (21)
  • [3] Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma
    Rodgers, Thomas D.
    Baran, Andrea
    Reagan, Patrick M.
    Casulo, Carla
    Zent, Clive
    Evans, Andrew
    Burack, Richard
    Williams, AnnaLynn M.
    Friedberg, Jonathan W.
    Barr, Paul M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : E33 - +
  • [4] Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group
    Naoki Wada
    Junichiro Ikeda
    Masaharu Kohara
    Hiroyasu Ogawa
    Masayuki Hino
    Shirou Fukuhara
    Akihisa Kanamaru
    Haruo Sugiyama
    Yuzuru Kanakura
    Eiichi Morii
    Katsuyuki Aozasa
    Virchows Archiv, 2009, 455 : 285 - 293
  • [5] Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group
    Wada, Naoki
    Ikeda, Junichiro
    Kohara, Masaharu
    Ogawa, Hiroyasu
    Hino, Masayuki
    Fukuhara, Shirou
    Kanamaru, Akihisa
    Sugiyama, Haruo
    Kanakura, Yuzuru
    Morii, Eiichi
    Aozasa, Katsuyuki
    VIRCHOWS ARCHIV, 2009, 455 (03) : 285 - 293
  • [6] Enrollment of high-risk patients with diffuse large B-cell lymphoma in clinical trials.
    Loh, Kah Poh
    Baran, Andrea
    Hu, John
    Casulo, Carla
    Barr, Paul M.
    Friedberg, Jonathan W.
    Reagan, Patrick Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma -: a Nordic Lymphoma Group study
    Jerkeman, M
    Anderson, H
    Dictor, M
    Kvaloy, S
    Åkerman, M
    Cavallin-Ståhl, E
    ANNALS OF HEMATOLOGY, 2004, 83 (07) : 414 - 419
  • [8] Bcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma
    Hallack Neto, Abrahao Elias
    Coelho Siqueira, Sheila Aparecida
    Dulley, Frederico Luiz
    Chauobah, Alfredo
    Belesso, Marcelo
    Saboia, Rosaura
    Ruiz, Milton Artur
    Fischer Chamone, Dalton Alencar
    Pereira, Juliana
    SAO PAULO MEDICAL JOURNAL, 2010, 128 (01): : 14 - 17
  • [9] Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study
    M. Jerkeman
    H. Anderson
    M. Dictor
    S. Kvaløy
    M. Åkerman
    E. Cavallin-Ståhl
    Annals of Hematology, 2004, 83 : 414 - 419
  • [10] Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma -: A Nordic Lymphoma Group study
    Jerkeman, M
    Åman, P
    Cavallin-Stahl, E
    Torlakovic, E
    Åkerman, M
    Mitelman, F
    Fioretos, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (01) : 161 - 165